Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040572 · ClinicalTrials.gov registry record
Laparoscopic Revision Gastric Bypass for Weight Recidivism
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 132
- Enrollment target
NCT01040572: Completed study, sponsored by University of California, San Francisco.
NCT01040572 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040572 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The main aim of this study is to analyze and report traditional, patient-centered, and composite intermediate-term outcomes after laparoscopic revision Roux-en-Y gastric bypass surgery for weight recidivism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2009-10 |
| Est. Completion | 2009-12 |
What the finished NCT01040572 record still lists
NCT01040572 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01040572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01040572 about?
NCT01040572 is a clinical study titled "Laparoscopic Revision Gastric Bypass for Weight Recidivism". The main aim of this study is to analyze and report traditional, patient-centered, and composite intermediate-term outcomes after laparoscopic revision Roux-en-Y gastric bypass surgery for weight recidivism.
What is the current status of trial NCT01040572?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2009-10. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT01040572?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia